H. Lundbeck A/S
- Country
- π©π°Denmark
- Ownership
- Public, Subsidiary
- Established
- 2000-01-01
- Employees
- 5.6K
- Market Cap
- -
- Website
- http://www.lundbeck.com
A Trial of Lu AF82422 in Participants With Multiple System Atrophy (MSA)
- First Posted Date
- 2024-11-26
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 360
- Registration Number
- NCT06706622
- Locations
- πΊπΈ
University Nebraska Medical Center, Omaha, Nebraska, United States
πΊπΈColumbia University Medical Center - The Neurological Institute of New York, New York, New York, United States
π¦πΊWestmead Hospital, Westmead, New South Wales, Australia
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 150
- Registration Number
- NCT06701526
- Locations
- πΊπΈ
Neuroscience Research Center, LLC, Canton, Ohio, United States
A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 40
- Registration Number
- NCT06578585
- Locations
- πΊπΈ
Clinical Neuroscience Solutions, Orlando, Florida, United States
πΊπΈNeuroTrials Research, Atlanta, Georgia, United States
πΊπΈFuture Search Trials, Austin, Texas, United States
A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 19
- Registration Number
- NCT06557850
- Locations
- π΅π±
Uniewrsyteckie Centru Kliniczne, Katowice, Poland
π΅π±Jagiellonian University Medical College, Krakow, Lesser Poland Voivodeship, Poland
π§π¦University Clinical Center of The Republic Of Srpska, Banja Luka, Republika Srpska, Bosnia and Herzegovina
A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 18
- Registration Number
- NCT06471829
- Locations
- π¬πͺ
Ltd Tbilisi Central Hospital, Tbilisi, Georgia
π¬πͺLtd Aversi Clinic, Tbilisi, Georgia
π«π·Assistance Publique Hopitaux de Marseille (AP-HM) - Hopital La Conception, Marseille, France
A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy Men
- First Posted Date
- 2024-03-29
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 8
- Registration Number
- NCT06337110
- Locations
- π¬π§
Fortrea Clinical Research Unit Ltd, Leeds, United Kingdom
A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 898
- Registration Number
- NCT06323928
- Locations
- π¨πΏ
Axon Clinical s r.o, Praha 5, Czechia
π¨πΏNeurologicka ordinace FORBELI sro, Praha 6, Czechia
π¨πΏInstitut neuropsychiatricke pece, Praha 8, Czechia
A Trial Investigating Lu AF28996 in Healthy Adult Participants
- Conditions
- Healthy Participants
- Interventions
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 22
- Registration Number
- NCT06277609
- Locations
- πΊπΈ
Covance Dallas CRU, Dallas, Texas, United States
A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian Adults
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 24
- Registration Number
- NCT06258720
- Locations
- π¨π³
Zhongshan Hospital Fudan University, Shanghai, China
A Trial Investigating the Pain-relieving Properties of Lu AG06474 in Healthy Adult Participants
- Conditions
- Healthy Participants
- Interventions
- First Posted Date
- 2023-10-11
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 26
- Registration Number
- NCT06077786
- Locations
- π³π±
Centre for Human Drug Research, Leiden, Netherlands